Suctioning Flexible Ureteroscopy With Intelligent Control of Renal Pelvic Pressure

Sponsor
The Affiliated Ganzhou Hospital of Nanchang University (Other)
Overall Status
Unknown status
CT.gov ID
NCT02734914
Collaborator
(none)
60
2
27

Study Details

Study Description

Brief Summary

This study evaluates the safety and efficacy of the suctioning flexible ureteroscopy(SF-URS) with automatic control of renal pelvic pressure for the treatment of upper urinary calculi using a prospective, randomized design. Half of participants will receive suctioning flexible ureteroscopy with automatic control of renal pelvic pressure, while the other half participants will receive retrograde intrarenal surgery using the classic flexible ureteroscopy.

Condition or Disease Intervention/Treatment Phase
  • Device: SF-URS with automatic control of RPP
  • Device: conventional F-URS
N/A

Detailed Description

Retrograde intrarenal surgery using flexible ureteroscope has become the first-line treatment for renal calculi < 3.0 cm and is recommended by the European Association of Urology due to its minimally-invasive nature and satisfactory result.

However, high perfusion rate leads to renal pelvic pressure increase, resulting in absorption of liquid, bacteria, and endotoxin into blood, followed by short-term complications such as systemic inflammatory response syndrome(SIRS , 8.1%), sepsis (0-4.5%), renal pelvic and ureteral tumor spread, and long-term complication of renal function impairment. Currently the commonly used flexible ureteroscope sheath (ureteral access sheath, UAS) reduces the renal pelvic pressure to a certain extent, but still can not control and monitor the renal pelvic pressure to reduce the incidence of complications, which, limit the clinical application of ureteroscopy.

Recently, the investigators present a novel technique of SF-URS with automatic control of renal pelvic pressure. In this study, transverse comparison is designed to evaluate the safety and efficacy of the suctioning flexible ureteroscopy with automatic control of renal pelvic pressure for the treatment of renal calculi.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Safety and Efficacy of Suctioning Flexible Ureteroscopy With Automatic Control of Renal Pelvic Pressure : A Clinical Randomized,Controlled Study
Study Start Date :
May 1, 2016
Anticipated Primary Completion Date :
Jul 1, 2018
Anticipated Study Completion Date :
Aug 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: SF-URS with automatic control of RPP

Participants in SF-URS with automatic control of renal pelvic pressure (RPP) group undergo ureteroscopy using the intelligent pressure control device (Medical irrigation and suctioning platform with pressure feedback function, and suctioning ureteral access sheath with function of pressure measuring).

Device: SF-URS with automatic control of RPP
A new F-URS monitoring and control of RPP using intelligent pressure control device

Active Comparator: conventional F-URS

Participants in conventional F-URS group undergo ureteroscopy using the classic flexible ureteroscope.

Device: conventional F-URS
Ureteroscopy will be conducted using the ureteral access sheath from Cook Medical to treat renal calculi.

Outcome Measures

Primary Outcome Measures

  1. stone-free rate [4 weeks post-operatively]

    Number of participants undergo novel or conventional F-URS surgeries without residual calculus/Total number of participants in each group *100%

Secondary Outcome Measures

  1. stone-free rate [One day post-operatively]

    Number of participants undergo novel or conventional F-URS surgeries without residual calculus/Total number of participants in each group *100%

  2. Complication rates [Within 4 weeks after surgery]

    Number of participants undergo novel or conventional F-URS surgeries suffer complications associated with the surgery (i.e. pain(NRS≥4), hematuria, T≥38℃, serum white blood cell≥12×〖10〗^9/L ,serum white blood cell<4×〖10〗^9/L, perforation, etc.)/Total number of participants in each group *100%

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Subject has provided informed consent and indicated a willingness to comply with study treatments

  • Subject has a diagnosis of renal stones according to computer tomography (CT) results

  • Subject is 18-75 yrs of age

  • Subject has a single stone < 3 cm in size, or multiple stones < 3 cm in cumulative size

  • Subject has a serum creatinine level within the normal range for the study center

Exclusion Criteria:
  • The patient who do not agree with the intention of the clinical study.

  • Subject needs bilateral procedures within one-stage ureteroscopy

  • Subject has an active urinary tract infection (e.g., cystitis, prostatitis, urethritis, etc.) and severe hematuria

  • Subject has been diagnosed with a urethral stricture or bladder neck contracture

  • Subject has a disorder of the coagulation cascade system that would put the subject at risk for intraoperative or postoperative bleeding

  • Subject is unable to discontinue anticoagulant and antiplatelet therapy preoperatively (3-5 d)

  • Subject has other diseases and could not tolerate the endoscopic surgery

  • Subject has any kind of anatomic abnormality of the urinary system that might have an influence on the surgery

  • Subject has been diagnosed with hydronephrosis larger than 3 cm according to the B-scan ultrasonography examination

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • The Affiliated Ganzhou Hospital of Nanchang University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Leming Song, professor, The Affiliated Ganzhou Hospital of Nanchang University
ClinicalTrials.gov Identifier:
NCT02734914
Other Study ID Numbers:
  • GanzhouHNU
First Posted:
Apr 12, 2016
Last Update Posted:
Apr 12, 2016
Last Verified:
Apr 1, 2016
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 12, 2016